[1]
“CLINICOPATHOLOGYCAL FEATURES OF EPITHELIAL OVARIAN CARCINOMA FOLLOWING NEOADJUVANT CHEMOTHERAPY”, YHCĐ, vol. 67, no. CD16, Nov. 2026, doi: 10.52163/yhc.v67iCD16.6993.